Agenus (AGEN) Amortization of Deferred Charges (2014 - 2026)

Agenus' (AGEN) quarterly Amortization of Deferred Charges came in at $14.5 million in Q1 2026, up 14.81% year-on-year from $12.6 million in Q1 2025, and down 8.08% quarter-over-quarter from $15.8 million in Q4 2025.

Agenus (AGEN) Amortization of Deferred Charges (2014 - 2026) Analysis & Trends

Agenus' Amortization of Deferred Charges history runs 13 years deep, the most recent figure standing at $14.5 million for Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges rose 14.81% year-over-year to $14.5 million in Q1 2026; TTM through Mar 2026 was $56.3 million, a 44.32% decrease from a year earlier, with the FY2025 full-year figure at $54.4 million, down 53.9% from the prior year.
  • Amortization of Deferred Charges eased to $14.5 million in Q1 2026 per AGEN's latest filing, from $15.8 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $44.6 million in Q4 2023 and bottomed at $12.6 million in Q1 2025.
  • The 5-year median for Amortization of Deferred Charges is $17.3 million (2023), against an average of $20.6 million.
  • Across the five-year window, Amortization of Deferred Charges surged 143.23% in 2023 and slumped 64.13% in 2025, its largest moves.
  • Year by year, Amortization of Deferred Charges stood at $18.3 million in 2022, then jumped by 143.23% to $44.6 million in 2023, then sank by 53.7% to $20.6 million in 2024, then slipped by 23.56% to $15.8 million in 2025, then slipped by 8.08% to $14.5 million in 2026.
  • Per Business Quant, the three latest AGEN Amortization of Deferred Charges figures stand at $14.5 million (Q1 2026), $15.8 million (Q4 2025), and $13.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,538.84 Bn 65,538.56 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
4 BeOne Medicines 469.46 Bn 464.67 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.69 Bn 115.45 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.41 Bn 61.65 Bn 3.31 Bn
7 Belite Bio 62.84 Bn 62.84 Bn -
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.48 Bn 34.47 Bn 959.66 Mn
10 Agenus 230.70 Mn 195.70 Mn 33.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.50 Mn
Mar 31, 2026 14.50 Mn
Dec 31, 2025 15.77 Mn
Dec 31, 2025 15.77 Mn
Sep 30, 2025 12.99 Mn
Sep 30, 2025 12.99 Mn
Jun 30, 2025 13.05 Mn
Jun 30, 2025 13.05 Mn
Mar 31, 2025 12.63 Mn
Mar 31, 2025 12.63 Mn
Dec 31, 2024 20.64 Mn
Dec 31, 2024 20.64 Mn
Sep 30, 2024 36.20 Mn
Sep 30, 2024 36.20 Mn
Jun 30, 2024 31.67 Mn
Jun 30, 2024 31.67 Mn
Mar 31, 2024 29.60 Mn
Mar 31, 2024 29.60 Mn
Dec 31, 2023 44.57 Mn
Dec 31, 2023 44.57 Mn